Pharmaceutical formulations of amyloid inhibiting compounds

Details Pharmaceutical formulations of amyloid inhibiting compounds Pharmaceutical formulations of amyloid inhibiting compounds

A - Human Necessities

61

K

A61K 31/00 (2006.01) A61K 9/22 (2006.01) A61K 9/32 (2006.01) A61K 31/185 (2006.01) A61P 3/10 (2006.01) A61P 25/00 (2006.01) A61P 25/28 (2006.01) A61P 31/04 (2006.01) A61P 31/12 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2529268

Therapeutic formulations and methods for inhibiting amyloid deposition in a subject, whatever its clinical setting, are described. Therapeutic formulations and methods for preventing or treating amyloidosis and/or amyloid- related disease are also described.

Formulations thérapeutiques et procédés inhibant les dépôts amyloïdes chez un sujet, indépendamment des conditions cliniques. Des formulations thérapeutiques et des procédés permettant de prévenir ou de traiter l'amylose et/ou des conditions liées aux substances amyloïdes sont également décrits.

Affiliated with

Also associated with

Rating

Pharmaceutical formulations of amyloid inhibiting compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical formulations of amyloid inhibiting compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations of amyloid inhibiting compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1518112